Shadman Sakib Choudhury

Dr. Shadman Sakib Choudhury

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2025 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
SSSyed Moinuddin Satter
Syed Moinuddin Satter
SSSharmin Sultana
Sharmin Sultana
SCShadman Sakib Choudhury
Shadman Sakib Choudhury
WAWasik Rahman Aquib
Wasik Rahman Aquib
DRDewan Imtiaz Rahman
Dewan Imtiaz Rahman
CAChowdhury Rafiqul Ahsan
Chowdhury Rafiqul Ahsan
This study aimed to explore the humoral immune response and viral detection in the acute phase of Nipah virus (NiV) infection. The study explored clinical and laboratory data from all 22 human NiV cases detected during the 2023, 2024 and 2025 outbreaks in Bangladesh. Oropharyngeal swabs and serum samples were tested for NiV genomic material by real-time reverse transcriptase polymerase chain reaction (RT-PCR); humoral immune response was detected by enzyme-linked immunosorbent assay (ELISA) for immunoglobulin M (IgM) and G (IgG). A majority of cases were male (64%), and the overall median age of all cases was 21 (0-70) years. The case fatality rate (CFR) was 86% (19/22). 18 (82%) of the cases had evidence of primary infection (a history of recent consumption of raw date palm sap). Viremia on diagnosis resulted in 100% fatality, while CFR was 25% (1/4) in those without detectable viremia. All survivors tested IgG positive on diagnosis, compared to only a third of the fatal cases. Clearance of the virus from the oropharyngeal space started from the 16th to 20th day post-illness onset. The study provides insights into the clinical indices, humoral immune response, and viral detection during NiV infection. This could aid in diagnostic schedules, prognosis, as well as inform isolation and containment strategies.

11 February 2026 in The Lancet Regional Health - Southeast Asia
Verified
Journal Article
Open access
WAWasik Rahman Aquib
Wasik Rahman Aquib
UMUtpal K. Mondal
Utpal K. Mondal
ANArifa Nazneen
Arifa Nazneen
DRDewan Imtiaz Rahman
Dewan Imtiaz Rahman
SCShadman Sakib Choudhury
Shadman Sakib Choudhury
SSSyed Moinuddin Satter
Syed Moinuddin Satter
Since 2001, Bangladesh has experienced recurrent outbreaks of Nipah virus (NiV) infection. While acute-phase manifestations are well documented, long-term clinical and functional sequelae poorly characterized. We conducted a cross-sectional assessment of 52 adult NiV survivors in Bangladesh between November 2021 and February 2022 to document the persistence, severity, and functional impact of post infection symptoms. Symptom history, clinical evaluation, and functional status were assessed using structured questionnaires and the Washington Group Extended Set on Functioning (WG-ES). All the survivors reported fever during acute illness, with frequent symptoms including headache (71%), severe weakness (67%), and altered mental status (44%). Following recovery, survivors reported a wide range of symptoms including sleep disturbance (58%), gait disturbance (54%), chronic fatigue (52%), memory and concentration difficulties (54%) and myoclonus (48%). Neurological, musculoskeletal, and respiratory symptoms persisted with varying severity and chronicity. Functional assessments revealed notable disability in several domains, particularly anxiety (48%), mobility (31%), and cognition (25%). Although post-infection symptoms were common, 65% of survivors met criteria for disability in at least one functional domain, and 48% had disabilities across multiple domains. These findings highlight the substantial and enduring burden experienced by NiV survivors in Bangladesh. The range and persistence of sequelae in this cohort appear broader than previously documented in Malaysia–Singapore survivor studies; however, methodological differences limit formal comparison. As the largest clinical and functional assessment of NiV survivors to date, this study provides essential evidence to inform long-term care strategies and underscores the need for survivor-focused rehabilitation and monitoring in outbreak-prone settings. This study was supported by the 10.13039/100016302 Coalition for Epidemic Preparedness Innovations (CEPI) (Grant No: GR-02160). The funding body had no role in the study design; data collection, management, analysis, or interpretation; writing of the manuscript; or the decision to submit the manuscript for publication. The views and conclusions expressed in this manuscript are those of the authors and should not be construed as representing the official viewpoints of CEPI or the U.S. Centers for Disease Control and Prevention.

2 April 2026 in JMIR Formative Research
Verified
Journal Article
Open access
KCKamal Ibne Amin Chowdhury
Kamal Ibne Amin Chowdhury
FAFaruq Abdulla
Faruq Abdulla
SSS M Zafor Shafique
S M Zafor Shafique
LALaila Afroza
Laila Afroza
NNNisharggo Niloy
Nisharggo Niloy
SSSyed Moinuddin Satter
Syed Moinuddin Satter
Background: Nipah virus (NiV) infection is considered one of the deadliest infectious diseases, with a case fatality rate of approximately 71%. In Bangladesh, the primary risk factor for NiV infection is the consumption of raw date palm sap (DPS) contaminated with excreta from fruit bats (ie, members of the Pteropodidae family). Recently, the increasing use of social media among Bangladeshi youth has enabled business groups to widely advertise and sell raw DPS. This increased access, combined with young people perceiving consumption of raw DPS as an “adventurous event,” may facilitate an increase in incidences of NiV infection. Objective: We aimed to explore and document data from social media regarding raw DPS advertisements and consumption. Furthermore, we aimed to investigate the commercial distribution of raw DPS across the country. Methods: The data were accessed from common social media platforms used in Bangladesh, including Facebook and YouTube, between November 10, 2023, and January 31, 2024. We considered this period to capture public opinions, discussions, and reported incidents during the peak harvesting and consumption season of DPS. While DPS harvesting continues until March, early monitoring is essential for identifying the emerging concerns related to NiV transmission. Extracted variables were post dates and times, source locations, types of sources and posts, provider details (eg, sellers and gachis ), post descriptions, user reactions, views, comments, and shares. Particular emphasis was placed on identifying the districts of both DPS suppliers and recipients. We used R version 4.3.2 and Stata version 15 for analyzing statistical data and QGIS for geographic data. Results: Of 556 social media posts, 361 (64.9%) were advertisements promoting raw DPS. Few DPS-related posts were associated with raising awareness about DPS consumption and NiV infection. In total, 473,724 people interacted with the social media posts. The identification of supplier and recipient districts revealed 14 source districts of raw DPS. The majority of raw DPS were distributed from Rajshahi, Naogaon, Rajbari, and Faridpur, which are among the most NiV-prone districts. During the data collection period, we observed an average of 996 (SD 377) liters of raw DPS sold per day from multiple gachhis (sap collectors) and sellers (vendors) in Rajshahi. Conclusions: The marketing of raw DPS through digital media platforms has increased customer interest, as evidenced by the notably high level of public engagement observed on this topic within the Bangladeshi social media context. Distributing raw DPS using digital platforms is a marketing tool that significantly increases the availability of raw DPS to previously hard-to-reach markets and potentially increases individuals’ exposure to NiV infection. This study recommends a multidisciplinary approach, which incorporates context-specific public health investigations, policymaking, and digital media surveillance to address emerging public health concerns.

16 June 2026 in Vaccines
Verified
Journal Article
Open access
PDF file
MAMohammad Mamun Alam
Mohammad Mamun Alam
TATahsin Tabassum Anonto
Tahsin Tabassum Anonto
SKSinthia Karim
Sinthia Karim
GKGathoni Kamuyu
Gathoni Kamuyu
AAAli Azizi
Ali Azizi
MRMohammad Ziaur Rahman
Mohammad Ziaur Rahman
Background/Objectives: Nipah virus (NiV) is a highly pathogenic zoonotic virus with fatality rates exceeding 70% and causes recurring outbreaks in South and Southeast Asia. Reliable serological assays are critical for outbreak surveillance, diagnosis, and evaluation of vaccine-induced immune responses. This study aimed to develop and qualify an indirect enzyme-linked immunosorbent assay (ELISA) based on recombinant NiV glycoprotein G for the detection of virus-specific IgG antibodies in human serum. Methods: An indirect ELISA was developed and optimized for antigen concentration, blocking conditions, and serum dilution. The assay performance was evaluated using convalescent human sera from Bangladesh, along with the World Health Organization (WHO) International Standard for anti-Nipah virus antibodies, maintained and distributed by the National Institute for Biological Standards and Control (NIBSC). Analytical validation was conducted in accordance with ICH Q2 (R2) guidelines, including assessments of sensitivity, specificity, Precision, Linearity, and detection limits. Results: The assay demonstrated 100% sensitivity and specificity relative to reference sera. Intra-assay coefficients of variation ranged from 0.36% to 5.73%, and inter-assay variation was 4.16%, indicating high precision. The ELISA showed excellent Linearity (R2 > 0.995). The lower limit of detection was 0.51 IU/mL, and the lower limit of quantification was 0.98 IU/mL. Conclusions: The developed ELISA is a BSL-2-compatible, robust, and scalable platform suitable for serosurveillance and the assessment of vaccine-induced immunity in endemic regions. Calibration against an international standard supports its applicability for standardized antibody measurement. This assay provides a practical tool for NiV outbreak response and vaccine evaluation.

1 January 2026 in Neurology Research International
Verified
Journal Article
Open access
PDF file
DRDewan Imtiaz Rahman
Dewan Imtiaz Rahman
FAFaruq Abdulla
Faruq Abdulla
WAWasik Rahman Aquib
Wasik Rahman Aquib
MRMd Mustafizur Rahman
Md Mustafizur Rahman
Muhammad Rashedul AlamMuhammad Rashedul Alam
Muhammad Rashedul Alam
SSSyed Moinuddin Satter
Syed Moinuddin Satter
Introduction: Acute encephalitis syndrome (AES) is a severe inflammatory condition affecting the central nervous system, frequently leading to significant morbidity and mortality. Despite advancements in diagnostic techniques, the etiology of AES remains unidentified in a substantial number of cases, particularly in low‐ and middle‐income countries like Bangladesh. Understanding factors that predict outcomes in AES patients is crucial for improving management strategies and patient outcomes. Methods: We used data from the Nipah surveillance in Bangladesh, analyzing patients admitted with AES to 11 surveillance hospitals across diverse geographical regions in Bangladesh from January 2021 to December 2023. Trained surveillance team members screened patients and collected data through face‐to‐face interviews using a structured questionnaire, and surveillance physicians made decisions on enrollment as an AES case. Bivariate and multivariable logistic regression analyses were used to identify predictors of mortality. Results: A total of 12,603 AES patients were included, of whom 2,759 (22%) died. Mortality rates varied significantly across different administrative divisions, with the highest rates observed in the Rangpur division. Increased age, female sex, and delayed hospital admission were associated with higher odds of mortality. Patients from divisions like Rangpur and those aged 60 or over had notably higher odds of mortality, with adjusted odds ratios of 2.55 and 4.22, respectively. Clinical factors such as high pulse rate, ronchi, difficulty breathing, altered mental status, stiff neck, paralysis, and unconsciousness at admission were significantly associated with unfavorable outcomes. Discussion: The findings highlight significant geographical, demographic, and clinical predictors of mortality among AES patients in Bangladesh. Older age, delayed hospital admission, and certain reported clinical symptoms on admission increase the risk of death. The study underscores the importance of timely intervention and targeted management strategies, particularly in identified aforementioned high‐risk groups. Conclusion: Identifying predictors of adverse outcomes in AES patients can aid in developing early warning and triage systems, potentially enabling adequate resource allocation and the delivery of timely, personalized, and higher standard of care.